NXL CIK: 1527352

Nexalin Technology, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
0.75
FY22:
7.43
FY23:
3.43
FY24:
3.96
FY25:
4.30
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.00
FY22:
0.01
FY23:
0.20
FY24:
0.26
FY25:
0.34
Total assets
Change from FY21 to FY25
millions USD
FY21:
0.75
FY22:
7.43
FY23:
3.63
FY24:
4.22
FY25:
4.64

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
2.36
FY22:
1.95
FY23:
0.43
FY24:
0.55
FY25:
0.89
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.07
FY22:
0.00
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.68
FY22:
5.48
FY23:
3.21
FY24:
3.68
FY25:
3.75
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
0.75
FY22:
7.43
FY23:
3.63
FY24:
4.22
FY25:
4.64

All amounts in millions USD Data source:SEC EDGAR